articleJournal of Thrombosis and HaemostasisOct 19, 2007BRONZE OA

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Sahlgrenska University Hospital · Thrombosis Research Institute · +10 more institutions

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

983
total citations
FWCI
54.14
Percentile
100%
References
19
Citations per year

Authors

12

Topics & keywords

Keywords
  • Medicine
  • Dabigatran
  • Direct thrombin inhibitor
  • Randomized controlled trial
  • Anesthesia
  • Incidence (geometry)
  • Knee replacement
  • Venous thromboembolism
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.